The Institute of Pediatric Endocrinology, Diabetes and Metabolism, "Dana-Dwek" Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Diabetes Metab Res Rev. 2024 Feb;40(2):e3767. doi: 10.1002/dmrr.3767.
Advances in treatment could mitigate the expected adverse changes in the body composition of children and adolescents with type 1 diabetes (T1D).
To examine the evolution of weight status and body composition and their association with glycaemic control and partial clinical remission in youth with T1D.
Ninety-nine participants with T1D (median age 9.5 years [interquartile range 7.3, 12.9], 59.6% boys) were longitudinally followed for 3 years since diagnosis. Data at seven pre-determined time points were extracted from medical files. Outcome measures included body mass index (BMI) z-scores, muscle-to-fat ratio (MFR) z-scores, haemoglobin A1c (HbA1c) levels, continuous glucose monitoring metrics, and insulin dose-adjusted HbA1c (IDAA1c) levels.
The BMI z-scores increased significantly (p < 0.001) for both sexes, with no significant change in MFR z-scores over time. The girls had higher BMI z-scores (p < 0.001) and lower MFR z-scores than the boys (p = 0.016). The mean HbA1c levels decreased during the first month and at 3 months since diagnosis (p < 0.001), then plateaued and achieved a median overall HbA1c of 7.1% for the entire cohort. At 12 months, 37 participants (37.6%) were in partial clinical remission, as evidenced by IDAA1c ≤ 9. The odds of partial clinical remission at 2 years increased by 2.1-fold for each standard deviation increase in the MFR z-score (p < 0.001). Higher MFR z-scores were associated with better metabolic control.
Integration of body composition assessments could mitigate adverse body changes in paediatric patients with T1D.
治疗进展可以减轻 1 型糖尿病(T1D)患儿和青少年预期的身体成分不良变化。
研究体重状况和身体成分的演变及其与青少年 T1D 患者血糖控制和部分临床缓解的关系。
99 名 T1D 患者(中位年龄 9.5 岁[四分位距 7.3,12.9],59.6%为男性)自诊断后进行了 3 年的纵向随访。从病历中提取了七个预定时间点的数据。主要结局包括体质指数(BMI)z 评分、肌肉与脂肪比值(MFR)z 评分、糖化血红蛋白(HbA1c)水平、连续血糖监测指标和胰岛素剂量调整的糖化血红蛋白(IDAA1c)水平。
男女 BMI z 评分均显著升高(p<0.001),而 MFR z 评分在整个研究期间无明显变化。女孩的 BMI z 评分高于男孩(p<0.001),而 MFR z 评分低于男孩(p=0.016)。HbA1c 水平在诊断后第一个月和 3 个月时显著降低(p<0.001),然后趋于稳定,整个队列的 HbA1c 中位数达到 7.1%。12 个月时,37 名患者(37.6%)达到部分临床缓解,表现为 IDAA1c≤9。MFR z 评分每增加一个标准差,部分临床缓解的几率增加 2.1 倍(p<0.001)。较高的 MFR z 评分与更好的代谢控制相关。
身体成分评估的整合可以减轻 T1D 患儿的不良身体变化。